R. E. Haddock

1.2k total citations · 1 hit paper
12 papers, 954 citations indexed

About

R. E. Haddock is a scholar working on Pharmacology, Spectroscopy and Psychiatry and Mental health. According to data from OpenAlex, R. E. Haddock has authored 12 papers receiving a total of 954 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pharmacology, 3 papers in Spectroscopy and 3 papers in Psychiatry and Mental health. Recurrent topics in R. E. Haddock's work include Pharmacogenetics and Drug Metabolism (4 papers), Analytical Chemistry and Chromatography (3 papers) and Chemical Reactions and Isotopes (2 papers). R. E. Haddock is often cited by papers focused on Pharmacogenetics and Drug Metabolism (4 papers), Analytical Chemistry and Chromatography (3 papers) and Chemical Reactions and Isotopes (2 papers). R. E. Haddock collaborates with scholars based in United Kingdom and United States. R. E. Haddock's co-authors include MS Lennard, GT Tucker, H.K. Crewe, P. F. Langley, W. H. Greb, Barry D. Zussman, G. Mellows, C M Kaye, Margaret Johnson and David R. Nelson and has published in prestigious journals such as Drugs, Acta Psychiatrica Scandinavica and British Journal of Clinical Pharmacology.

In The Last Decade

R. E. Haddock

12 papers receiving 870 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The effect of selective serotonin re‐uptake inhibitors on cytochrome P4502D6 (CYP2D6) activity in human liver microsomes.

1992 396 citations H.K. Crewe, MS Lennard et al. British Journal of Clinical Pharmacology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
R. E. Haddock United Kingdom	8	431	368	278	147	109	12	954
Barry D. Zussman United Kingdom	15	344 0.8×	218 0.6×	253 0.9×	138 0.9×	152 1.4×	20	915
J. Van Harten Netherlands	17	315 0.7×	242 0.7×	312 1.1×	140 1.0×	103 0.9×	34	1.1k
H. Friedman United States	24	341 0.8×	227 0.6×	204 0.7×	228 1.6×	121 1.1×	53	1.3k
Soong T. Chiang United States	17	306 0.7×	227 0.6×	170 0.6×	92 0.6×	93 0.9×	35	800
Siu Wah Cheung Canada	12	221 0.5×	414 1.1×	150 0.5×	165 1.1×	121 1.1×	13	889
Michèle Jonzier-Perey Switzerland	15	268 0.6×	369 1.0×	291 1.0×	124 0.8×	135 1.2×	21	769
Edward J. Antal United States	19	306 0.7×	280 0.8×	174 0.6×	71 0.5×	161 1.5×	50	1.2k
K. Fredricson Overø Denmark	18	611 1.4×	322 0.9×	561 2.0×	282 1.9×	158 1.4×	39	1.4k
Alice I. Nichols United States	20	504 1.2×	326 0.9×	212 0.8×	114 0.8×	171 1.6×	42	1.2k
B. Alexanderson Sweden	13	349 0.8×	296 0.8×	254 0.9×	170 1.2×	134 1.2×	15	880

Countries citing papers authored by R. E. Haddock

Since Specialization

Citations

This map shows the geographic impact of R. E. Haddock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. E. Haddock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. E. Haddock more than expected).

Fields of papers citing papers by R. E. Haddock

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. E. Haddock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. E. Haddock. The network helps show where R. E. Haddock may publish in the future.

Co-authorship network of co-authors of R. E. Haddock

This figure shows the co-authorship network connecting the top 25 collaborators of R. E. Haddock. A scholar is included among the top collaborators of R. E. Haddock based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. E. Haddock. R. E. Haddock is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

1.

Haddock, R. E., et al.. (1999). Sibutramine pharmacokinetics in young and elderly healthy subjects. European Journal of Clinical Pharmacology. 54(11). 847–849. 48 indexed citations

2.

Clarke, S. E., Nigel Austin, J. C. Bloomer, et al.. (1994). Metabolism and disposition of¹⁴C-granisetron in rat, dog and man after intravenous and oral dosing. Xenobiotica. 24(11). 1119–1131. 24 indexed citations

3.

Crewe, H.K., et al.. (1992). The effect of selective serotonin re‐uptake inhibitors on cytochrome P4502D6 (CYP2D6) activity in human liver microsomes.. British Journal of Clinical Pharmacology. 34(3). 262–265. 396 indexed citations breakdown →

4.

Büscher, G., et al.. (1992). Lack of enterohepatic circulation of the active metabolite of nabumetone in humans.. PubMed. 36. 81–2. 4 indexed citations

5.

Haddock, R. E., et al.. (1992). The role of cytochrome P4502D6 in the metabolism of paroxetine by human liver microsomes.. British Journal of Clinical Pharmacology. 33(5). 521–523. 103 indexed citations

6.

Büscher, G., et al.. (1990). Nabumetone. Drugs. 40(Supplement 5). 67–70. 12 indexed citations

7.

Haddock, R. E.. (1990). Kinetics of granisetron hydrochloride-distribution, metabolism and excretion in rats and dogs following intravenous administration. Medical Entomology and Zoology. 24. 6821–6843. 3 indexed citations

8.

Haddock, R. E., et al.. (1989). Paroxetine: lack of effect on hepatic drug metabolizing enzymes. Acta Psychiatrica Scandinavica. 80(S350). 93–94. 7 indexed citations

9.

Haddock, R. E., et al.. (1989). Metabolic pathway of paroxetine in animals and man and the comparative pharmacological properties of its metabolites. Acta Psychiatrica Scandinavica. 80(S350). 24–26. 79 indexed citations

10.

Kaye, C M, R. E. Haddock, P. F. Langley, et al.. (1989). A review of the metabolism and pharmacokinetics of paroxetine in man. Acta Psychiatrica Scandinavica. 80(S350). 60–75. 208 indexed citations

11.

Haddock, R. E., et al.. (1984). Metabolism of nabumetone (BRL 14777) by various species including man. Xenobiotica. 14(4). 327–337. 64 indexed citations

12.

Haddock, R. E., et al.. (1983). Penetration of nabumetone into inflammatory exudates in the rat. Journal of Pharmacy and Pharmacology. 35(6). 358–362. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact